Trials / Sponsors / Apeiron Biologics
Apeiron Biologics
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Covid19 | Phase 1 | 2021-10-19 |
| Completed | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 COVID-19 | Phase 2 | 2020-04-30 |
| Completed | Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induc Radiation Induced Dermatitis | Phase 1 / Phase 2 | 2012-01-01 |
| Completed | Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) Pulmonary Diseases, Cardiovascular Diseases, Kidney Diseases | Phase 1 | 2009-04-01 |